HCW Biologics Inc

NASDAQ HCWB

Data sourced from iex and EODHD
Download Data

HCW Biologics Inc Income Statement 2019 - 2023

This table shows the Income Statement for HCW Biologics Inc going from 2019 until 2023. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Revenue
M 3 7 4 4 0
Cost of Revenue
M 3 4 1 - -
Gross Profit
M -1 3 -1 4 -
Operating Expenses
M 25 18 13 10 -
Selling, General, and Administrative Expenses (SG&A)
M 13 8 5 2 2
Research and Development (R&D) Expenses
M 7 9 8 7 5
Other Operating Expenses
M 5 0 0 0 -
Costs and Expenses
M 22 14 13 - -
Operating Income
M -26 -15 -13 -6 -7
Interest Expense
M 0 0 1 0 0
Non-operating Income/Expense
M 1 0 1 0 0
EBT
M -25 -15 -13 -6 -7
Income Tax Provision
M 0 0 -1 0 0
Income after Tax
M -25 -15 -12 -6 -7
Non-Controlling Interest
M - 0 0 1 0
Net Income
M - -15 -13 -7 -8
Shares (Basic, Weighted)
M - - - - -
Shares (Diluted, Weighted)
R 35,929,446.00 35,822,249.00 35,768,264.00 36,700,520.00 24,428,371.00
EBITDA
M -25 -15 -13 -5 -7
Depreciation and Amortization
M 1 0 1 1 0
EBIT
M -26 -15 -13 -6 -7
Income from Discontinued Operations
M - - - - -
Tax Rate (Effective)
% 0.00 1.20 3.93 0.38 0.99
Earnings Per Share (EPS), Basic
M - - - - -
Earnings Per Share (EPS), Diluted
M - 0 0 0 0
Gross Profit Margin
% -20.23 38.48 -13.26 100.00 -
Operating Income Margin
% -904.96 -224.32 -326.06 -142.07 -
Net Income Margin
% - -221.67 -313.74 -172.54 -
EBITDA Ratio
% -865.02 -219.78 -312.81 -127.53 -
EBIT Ratio
% -904.96 -224.32 -326.06 -142.07 -
EBT Ratio
% -879.52 -221.67 -313.74 -141.53 -

StockViz Staff

September 19, 2024

Any question? Send us an email